Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
NICE’s Preparations for Evaluating New Al...
By
HEOR Staff Writer
December 27, 2023
The Advent of Disease-Modifying Dementia Treatments (DMDTs) Recent years have seen significant strides in our understanding of dementia, particularly
ICER Report on Lecanemab: Efficacy, Cost, and Equity Concerns for Alzheimer...